biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > TT's Sappy Cap Plot

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 24, 2023 1:02am

67 Views

Post# 35603158

RE:RE:TT's Sappy Cap Plot

Have they passed on xB3? Besides Chiesi, who passed?

Did Chiesi and Protalix understand how to make fusion proteins with xB3?

Other companies have. MedImmune understood it.

Did Prothena have a payload that was worth advancing? I question that. And I know why I question it.

Why did LT, The Placee, Midatech, DrDR and Brother Mario want to buy Bioasis?

What did/does Bioasis have other than xB3?

The EGF stuff is worthless without xB3.

What was LT's play?

YOU DON'T HAVE AN ANSWER, Little TT.

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario